ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMRN Immuron Ltd

2.52
-0.02 (-0.79%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immuron Ltd IMRN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.02 -0.79% 2.52 14:00:11
Open Price Low Price High Price Close Price Previous Close
2.62 2.4815 2.62 2.52 2.54
more quote information »

Recent News

Date Time Source Heading
03/5/202420:00GLOBEImmuron Director Resignation
15/4/202420:00GLOBEImmuron to host Live Virtual Event
10/4/202420:00GLOBEImmuron Travelan® sales continued strong growth
08/3/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202422:00GLOBEImmuron Announces Positive Results Support Travelan®..
29/2/202400:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202422:00GLOBEImmuron Presentation Australian Biologics Festival 2024
14/2/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/2/202422:00GLOBEImmuron achieves record Travelan® sales
08/2/202422:00GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
17/1/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202422:00GLOBEImmuron achieves record half yearly Travelan® sales
22/12/202323:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202322:00GLOBEImmuron Clinical Trials Update
04/12/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202322:00GLOBEImmuron Announces First Patients Enrolled in Campylobacter..
28/11/202322:33GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
28/11/202322:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202323:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202310:00GLOBEImmuron CEO Steven Lydeamore Investor Webinar Presentation
14/11/202300:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202322:21GLOBEImmuron CEO Steven Lydeamore presented at AusBioInvest
23/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202321:00GLOBEImmuron Announces Travelan® Clinical Study Cohort 2..
11/10/202321:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/202321:00GLOBEImmuron achieves record quarterly Travelan® sales
28/9/202322:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202320:18EDGAR2Form 20-F - Annual and transition report of foreign private..
13/9/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202320:00GLOBEImmuron achieves record monthly Travelan® sales
11/9/202320:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202320:00GLOBEImmuron CEO, Steven Lydeamore to present at H.C. Wainwright
30/8/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202320:00GLOBEImmuron to present at the Military Health System Research..
09/8/202320:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202320:00GLOBEImmuron Announces First Patients Enrolled in Travelan®..
25/7/202311:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202320:00GLOBEImmuron CEO, Steven Lydeamore to present at Bioshares
11/7/202320:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202320:00GLOBEImmuron Business Update - Ateria Health launches Juvia™ in..
05/7/202320:00GLOBEImmuron FY23 Sales increase 136% on FY22 Sales
30/6/202320:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202320:00GLOBEImmuron Chairman Transition
22/6/202320:00GLOBEImmuron Business Update: Letter to Shareholders

Your Recent History

Delayed Upgrade Clock